Identification of Novel Activators of Constitutive Androstane Receptor from FDA-Approved Drugs by Integrated Computational and Biological Approaches

Author： Lynch Caitlin  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.30, Iss.2, 2013-02, pp. : 489-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Public misconceptions about FDA-approved drugs

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of the constitutive androstane receptor

By Lamba Jatinder K  

Pharmacogenomics, Vol. 9, Iss. 1, 2008-01 ,pp. : 71-83

Future Medicine

Access to resources Recommend Favorite

Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)

By Chang Thomas   Waxman David  

Drug Metabolism Reviews, Vol. 38, Iss. 1-2, 2006-05 ,pp. : 51-73

Informa Healthcare

Access to resources Recommend Favorite

Transactivation Assays that Identify Indirect and Direct Activators of Human Pregnane X Receptor (PXR, NR1I2) and Constitutive Androstane Receptor (CAR, NR1I3)

By  

Drug Metabolism Letters, Vol. 11, Iss. 2, 2018-02 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite